There is a great deal of variability in how a patient responds to medications due to the genes that govern drug metabolism, and this can therefore impact drug efficacy. Pharmacogenomics empowers the doctor to provide specific medical interventions, based on the patient’s genetic profile, and replaces the current trial and error approach to drug therapy.

mypainRx analyses genetic variants that affect the metabolism of pain medications such as:

  • Fibromyalgia Agents
  • Muscle Relaxants
  • NSAIDs
  • Opioids


Click here for the full list of medications reported on in mypainRx


Benefits of pharmacogenomic testing include

  • Improve efficacy of treatment, improved quality of life for the patient
  • Decrease treatment time
  • Save money on ineffective medications
  • Patients avoid unpleasant or possible fatal side effects of some medications